Tak Mukohira

Mitsubishi Chemical Corp. engages in the manufacture and sale of performance products and industrial materials. Its products and materials are used in automobiles and aircrafts; packaging, labels and films; IT, electronics and displays; environment and energy; and medical, food and bio products. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan.

MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts.

The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan.

Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a pharmaceutical company based in Jersey City, NJ. MTPA is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) and was established to develop and advance their pipeline as well as commercialize approved pharmaceutical products in the United States. MTPA delivers innovative solutions that are guided by patients' unmet medical needs.

Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Holdings America, Inc. manufactures and distributes pharmaceuticals, pet products & medicines. The company is based in Jersey City, NJ.

Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Holdings America, Inc. is a company that manufactures and supplies chemical products. The company is based in New York, NY.

Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017.

Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.

SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA.